| Trial Identifier: | D3253C00001 |
| Sponsor: | AstraZeneca |
| Start Date: | October 2019 |
| Primary Completion Date: | August 2023 |
| Study Completion Date: | March 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Country | Location |
|---|---|
| BE | Brussel, BE, 1090 |
| BE | Brussel, BE, 1070 |
| CA, AB | Calgary, AB, CA, T2N 4Z6 |
| CA, ON | Hamilton, ON, CA, L8N 4A6 |
| CA, ON | Toronto, ON, CA, M5T 3A9 |
| CA, ON | Toronto, ON, CA, M5G 1E2 |
| DE | Bamberg, DE, 96049 |
| DE | Freiburg, DE, 79106 |
| DE | Hamburg, DE, 20251 |
| DE | Kirchheim, DE, 73230 |
| DE | Lübeck, DE, 23538 |
| FR | Dijon Cedex, FR, 21079 |
| FR | Marseille, FR, 13915 |
| FR | Montpellier, FR, 34090 |
| FR | Nantes Cedex 1, FR, 44093 |
| FR | Paris, FR, 75877 |
| FR | PARIS, FR, 75014 |
| FR | SURESNES CEDEX, FR, 92151 |
| FR | Toulouse, FR, 31059 |
| GB | Cambridge, GB, CB2 0QQ |
| GB | Leicester, GB, LE3 9QP |
| GB | London, GB, SE19RT |
| GB | Portsmouth, GB, PO6 3LY |
| IL | Ashkelon, IL, 7830604 |
| IL | Beer Sheva, IL, 84101 |
| IL | Jerusalem, IL, 91120 |
| IL | Ramat Gan, IL, 52621 |
| IL | Rehovot, IL, 7661041 |
| IL | Tel Aviv, IL, 6423906 |
| IT | Cuneo, IT, 12100 |
| IT | Firenze, IT, 50141 |
| IT | Milano, IT, 20132 |
| IT | MILANO, IT, 20162 |
| IT | NAPOLI, IT, 80131 |
| IT | Roma, IT, 00168 |
| IT | Torino, IT, 10128 |
| JP | Chiba-shi, JP, 260-0877 |
| JP | Kita-gun, JP, 761-0793 |
| JP | Sagamihara-shi, JP, 228-0815 |
| JP | Sendai-shi, JP, 980-8574 |
| JP | Shinjuku-ku, JP, 162-8666 |
| US, CO | Denver, CO, US, 80206 |
| US, MI | Ann Arbor, MI, US, 48109 |
| US, MN | Rochester, MN, US, 55905-0001 |
| US, NM | Albuquerque, NM, US, 87106 |
| US, NY | Great Neck, NY, US, 11021 |
| US, NY | New York, NY, US, 10021 |
| US, PA | Philadelphia, PA, US, 19104 |
| US, TX | Denison, TX, US, 75020 |
| US, WA | Seattle, WA, US, 98115 |